Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor Treatment-Naive Patients with Myelofibrosis: Results of the MANIFEST-2 Randomized, Double-Blind, Phase 3 StudyRaajit K. Rampal,Sebastian Grosicki,Dominik Chraniuk,Elisabetta Abruzzese,Prithviraj Bose,Aaron T. Gerds,Alessandro M. Vannucchi,Francesca Palandri,Sung-Eun Lee,Vikas Gupta,Alessandro Lucchesi,Stephen T. Oh,Andrew T. Kuykendall,Andrea Patriarca,Alberto Alvarez-Larran,Ruben Mesa,Jean-Jacques Kiladjian,Moshe Talpaz, Morgan Harris, Sarah-Katharina Kays, Anna-Maria Jegg,Qing Li, Barbara Brown,Claire N. Harrison, John MascarenhasBLOOD（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
